Wu J H, Herp A, Wu A M
Department of Microbiology and Immunology, Chang-Gung Medical College, Kwei-san, Tao-yuan, Taiwan, Republic of China.
Mol Immunol. 1993 Mar;30(4):333-9. doi: 10.1016/0161-5890(93)90062-g.
To define carbohydrate specificity of Ricinus communis agglutinin (RCA1), the combining site of RCA1 was further characterized by quantitative precipitin (QPA) and precipitin-inhibition assays (QPIA). Among the oligosaccharides tested for QPIA, Gal beta 1-->4GlcNAc (II, human blood group type II precursor sequence) was found to be 7.1 times more active than Gal beta 1-->3GalNAc (T, Thomsen-Friedenreich sequence) and about 1.7 times more active than the other three disaccharides tested--Gal beta 1-->4Man, Gal beta 1-->3DAra and Gal beta 1-->6GalNAc. Gal alpha 1-->4Gal, the receptor of the uropathogenic E. coli ligand was 3.6 times less active than the II sequence. These results indicate that the beta 1-->4 linkage of the terminal Gal to subterminal GlcNAc is important as this beta 1-->4GlcNAc sequence is at least 1.6 times more active than other types of disaccharides. Among the glycoproteins examined for QPA, native and desialized bovine submandibular glycoproteins, native and desialized human plasma alpha 1-acid glycoproteins, as well as crude hog stomach mucin and its three mild acid hydrolyzed products reacted well with the lectin. These glycoproteins precipitated over 75% of the lectin nitrogen added indicating that RCA1 has the ability to recognize Gal beta 1-->4/3GlcNAc and/or the related residues at the non-reducing ends and at positions in the interior of the chains. However, Tn (GalNAc alpha 1-->Ser/Thr sequence) rich glycoproteins such as desialized ovine submandibular glycoprotein and desialized armadillo salivary glycoprotein, in which over 90% of the carbohydrate side chains are Tn determinants with none or only a trace of I/II or T determinants, precipitated poorly with RCA1. From the present and previous results obtained, the carbohydrate specificity of RCA1 can be constructed and summarized in decreasing order by lectin determinants as follows: II (Gal beta 1-->4GlcNAc) > I (Gal beta 1-->3GlcNAc) > E (Gal alpha 1-->4Gal) and B (Gal alpha 1-->3Gal) > T (Gal beta 1-->3GalNAc), while Tn (GalNAc alpha 1-->Ser/Thr) is a poor inhibitor.
为了确定蓖麻凝集素(RCA1)的碳水化合物特异性,通过定量沉淀反应(QPA)和沉淀抑制试验(QPIA)进一步表征了RCA1的结合位点。在用于QPIA测试的寡糖中,发现β1,4-半乳糖基-N-乙酰葡糖胺(II型,人类血型II型前体序列)的活性比β1,3-半乳糖基-N-乙酰半乳糖胺(T抗原,汤姆森-弗里德赖希序列)高7.1倍,比其他三种测试的二糖——β1,4-半乳糖基-甘露糖、β1,3-半乳糖基-阿拉伯糖和β1,6-半乳糖基-N-乙酰半乳糖胺——的活性高约1.7倍。α1,4-半乳糖基-半乳糖,即尿路致病性大肠杆菌配体的受体,其活性比II型序列低3.6倍。这些结果表明,末端半乳糖与亚末端N-乙酰葡糖胺的β1,4连接很重要,因为这种β1,4-N-乙酰葡糖胺序列的活性至少比其他类型的二糖高1.6倍。在用于QPA测试的糖蛋白中,天然和去唾液酸的牛下颌下糖蛋白、天然和去唾液酸的人血浆α1-酸性糖蛋白,以及粗制猪胃粘蛋白及其三种轻度酸水解产物与凝集素反应良好。这些糖蛋白沉淀了超过75%添加的凝集素氮,表明RCA1能够识别β1,4/3-半乳糖基-N-乙酰葡糖胺和/或在非还原末端以及链内部位置的相关残基。然而,富含Tn(N-乙酰半乳糖胺α1-丝氨酸/苏氨酸序列)的糖蛋白,如去唾液酸的羊下颌下糖蛋白和去唾液酸的犰狳唾液糖蛋白,其中超过90%的碳水化合物侧链是Tn决定簇,没有或只有微量的I/II或T决定簇,与RCA1的沉淀效果很差。根据目前和之前获得的结果,RCA1的碳水化合物特异性可以按照凝集素决定簇的降序构建和总结如下:II型(β1,4-半乳糖基-N-乙酰葡糖胺)>I型(β1,3-半乳糖基-N-乙酰葡糖胺)>E型(α,4-半乳糖基-半乳糖)和B型(α1,3-半乳糖基-半乳糖) > T型(β1,3-半乳糖基-N-乙酰半乳糖胺),而Tn(N-乙酰半乳糖胺α1-丝氨酸/苏氨酸)是一种较差的抑制剂。